,,ii  #aadth ,,congress  #b;d ,session  
,s4 #bhfa  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,april #bg1    
#bjaf ,mr4 ,rounds introduced the       
following bill2 which was read twice and
 referred to the ,committee on ,armed   
,services  ,a ,,bill  ,to require the   
,secretary of ,defense to review and    
monitor prescribing practices at        
military treatment facilities of        
pharmaceutical agents for the treatment 
of post-traumatic stress4  #a4 ,short   
title  ,this ,act may be cited as the   
,post-,traumatic ,stress ,disorder      
,medication ,prescribing ,improvement   
,act of #bjaf4  #b4 ,requirement to     
review and monitor prescribing practices
 at military treatment facilities of    
pharmaceutical agents for treatment of  
post-traumatic stress  7a7 ,in general  
,not later than #ahj days after the date
 of the enactment of this ,act1 the     
,secretary of ,defense shall--  7#a7    
conduct a comprehensive review of the   
prescribing practices at military       

treatment facilities of pharmaceutical  
agents for the treatment of             
post-traumatic stress2  7#b7 implement a
 process or processes to monitor the    
prescribing practices at military       
treatment facilities of pharmaceutical  
agents that are discouraged from use    
under the ,,va_/,,dod ,clinical         
,practice ,guideline for ,management of 
,post-,traumatic ,stress2 and  7#c7     
implement a plan to address any         
deviations from such guideline in       
prescribing practices of pharmaceutical 
agents for management of post-traumatic 
stress at such facilities4  7b7         
,pharmaceutical agent defined ,in this  
section1 the term pharmaceutical agent  
has the meaning given that term in      
section #ajgd;g7g7 of title #aj1 ,united
 ,states ,code4